| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 1773 |
| 1 | DEXAMETHASONE 1.5 MG | 1772 |
| 2 | CYCLOPHOSPHAMIDE | 1613 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 1613 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1613 |
| 5 | RITUXIMAB | 1507 |
| 6 | LENALIDOMIDE | 1506 |
| 7 | VENETOCLAX | 1168 |
| 8 | METHOTREXATE SODIUM | 1160 |
| 9 | METHOTREXATE | 1030 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEDAZURIDINE AND DECITABINE | 129 | 0.1318 |
| 1 | IMETELSTAT SODIUM | 20 | 0.1075 |
| 2 | OBECABTAGENE AUTOLEUCEL | 6 | 0.0845 |
| 3 | IDECABTAGENE VICLEUCEL | 49 | 0.0395 |
| 4 | LIFILEUCEL | 10 | 0.0351 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 81 | 0.0333 |
| 6 | DEXTROSE AND SODIUM CHLORIDE | 5 | 0.0299 |
| 7 | TAFASITAMAB-CXIX | 26 | 0.0287 |
| 8 | IFOSFAMIDE FOR INJECTION | 557 | 0.0259 |
| 9 | ZONGERTINIB | 4 | 0.0240 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 3170 |
| 1 | Alkylating Drug [EPC] | 2212 |
| 2 | Thalidomide Analog [EPC] | 1829 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1747 |
| 4 | Kinase Inhibitor [EPC] | 1657 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1518 |
| 6 | Platinum-based Drug [EPC] | 1422 |
| 7 | BCL-2 Inhibitor [EPC] | 1168 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 1118 |
| 9 | Topoisomerase Inhibitor [EPC] | 993 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 81 | 0.0333 |
| 1 | Interferon gamma Blocker [EPC] | 5 | 0.0211 |
| 2 | CD22-directed Immunoconjugate [EPC] | 59 | 0.0197 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 199 | 0.0196 |
| 4 | BCL-2 Inhibitor [EPC] | 1168 | 0.0186 |
| 5 | Topoisomerase Inhibitor [EPC] | 993 | 0.0129 |
| 6 | Hematopoietic Stem Cell Mobilizer [EPC] | 18 | 0.0121 |
| 7 | Interleukin-6 Antagonist [EPC] | 6 | 0.0092 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 54 | 0.0092 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 30 | 0.0092 |